Other predictors of beneficial response to autologous DC vaccine were younger age, gross resection of tumour, tumour showing infiltrating lymphocytes and peripheral blood mononuclear cells with lower PD-1+/CD8+ ratio [102]. This evidence concerns the gene CD8A and neoplasm.